Stocks Health care BIAF
NASDAQ · Health carebioAffinity Technologies, Inc. (BIAF)
bioAffinity Technologies, Inc. brought in $5.9M of revenue over the twelve months to June 30, 2026, down 23.2% from a year earlier. It posted a net loss of $15.2M. In fiscal 2025 capital spending exceeded operating cash flow by $9.4M. At June 30, 2026 it held $2.4M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 7, 2026.
Watch BIAF in 60 secondsWhat bioAffinity Technologies, Inc. does
bioAffinity Technologies, Inc. is registered with the SEC under industry code SIC 8731 (Services-Commercial Physical & Biological Research). Its shares trade on NASDAQ under the ticker BIAF.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $6.2M | -$14.9M | -$8.66 | -$9.4M |
| 2024 | $9.4M | -$9M | -$22.50 | -$7.3M |
| 2023 | $7.9M | -$7.9M | -$27.30 | -$6.1M |
| 2022 | $6.9M | -$8.2M | -$54.30 | -$4.3M |
| 2022 | n/a | -$6.3M | -$70.80 | n/a |
Full financial statements: income, balance sheet and cash flow
Where BIAF ranks in Health care
Latest SEC filings
What bioAffinity Technologies, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 22, 2026Other event 8-K
- September 17, 2026Other event 8-K
- September 11, 2026
- September 9, 2026Other event 8-K
- September 8, 2026
- September 3, 2026Other event 8-K
- September 3, 2026
- September 1, 2026Other event 8-K
- August 27, 2026
- August 20, 2026
Questions about BIAF
What does bioAffinity Technologies, Inc. do?
bioAffinity Technologies, Inc. is registered with the SEC under industry code SIC 8731 (Services-Commercial Physical & Biological Research). Its shares trade on NASDAQ under the ticker BIAF.
Is bioAffinity Technologies, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $15.2M on revenue of $5.9M.
How much revenue does bioAffinity Technologies, Inc. make?
Over the twelve months to June 30, 2026 bioAffinity Technologies, Inc. reported revenue of $5.9M. That is 23.2% less than a year earlier.
When did bioAffinity Technologies, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 7, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the other event from September 22, 2026.
Similar companies
Compare BIAF with
Follow BIAF
Get an email when bioAffinity Technologies, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow BIAF: get an email when it filesWhere the numbers come from
Financial figures are the values bioAffinity Technologies, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.